Nov 14, 2024 04:05PM
Nov 11, 2024 04:05PM
Oct 31, 2024 09:17AM
Oct 30, 2024 07:31AM
Oct 30, 2024 07:30AM
Oct 30, 2024 07:30AM
Sep 24, 2024 07:34AM HOOKIPA Pharma (HOOK) to Present Strong Preclinical HB-700 Dataset
Sep 24, 2024 07:30AM
Aug 8, 2024 04:30PM
Jul 22, 2024 08:31AM
Jul 22, 2024 08:30AM
Jun 4, 2024 01:03PM
Jun 4, 2024 01:00PM
May 23, 2024 05:01PM HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
May 9, 2024 07:01AM
Apr 26, 2024 06:59AM
Apr 25, 2024 07:01AM
Apr 25, 2024 07:01AM
Apr 24, 2024 07:01AM
Apr 24, 2024 07:01AM
Apr 10, 2024 07:01AM HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
Mar 22, 2024 07:01AM
Dec 21, 2023 07:01AM
Dec 21, 2023 07:01AM
Nov 20, 2023 07:02AM
Nov 20, 2023 07:01AM
Nov 3, 2023 12:01PM
Oct 22, 2023 06:01AM HOOKIPA Pharma Presents Additional Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab as First-Line Treatment in Patients with HPV16+ Head and Neck Cancers at European Society for Me
May 31, 2023 04:45PM
May 22, 2023 08:00AM
Mar 15, 2023 07:00AM
Mar 15, 2023 07:00AM
Feb 13, 2023 07:00AM
Feb 13, 2023 07:00AM
Feb 13, 2023 07:00AM HOOKIPA Achieves $10 Million Milestone Payment in Development of Immunotherapy for KRAS-Mutated Cancers
Nov 14, 2022 07:00AM
Nov 14, 2022 07:00AM
Aug 11, 2022 07:00AM
Aug 11, 2022 07:00AM
Jul 25, 2022 08:02AM
Jul 25, 2022 08:00AM
Jun 6, 2022 05:49AM HOOKIPA Pharma Inc. (HOOK) Reports Positive Phase 1 HB-200 Data, Plans Phase 2
Jun 5, 2022 09:00AM
Jun 5, 2022 09:00AM
May 26, 2022 05:15PM
May 26, 2022 05:15PM
Mar 24, 2022 07:08AM
Mar 24, 2022 07:00AM
Mar 24, 2022 07:00AM HOOKIPA Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Outlook
Feb 16, 2022 09:20AM

322,245 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All